DENOVAMED
DeNovaMed is an early-stage pharmaceutical company specializing in new therapeutic approaches to combat bacterial infections. Their team has deep domain expertise in drug discovery, microbiology, and bacterial lipid metabolism, which they use to create novel antibiotics. DeNovaMed is based in Halifax, Nova Scotia, Canada.
DENOVAMED
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2006-01-01
Address:
Halifax, Nova Scotia, Canada
Country:
Canada
Website Url:
http://www.denovamed.com
Total Employee:
11+
Status:
Active
Contact:
902-470-7523
Email Addresses:
[email protected]
Total Funding:
500 K CAD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Current Employees Featured
Founder
Investors List
Innovacorp
Innovacorp investment in Seed Round - DeNovaMed
Official Site Inspections
http://www.denovamed.com
- Host name: buck.tchmachines.com
- IP address: 208.76.80.43
- Location: Oxford United States
- Latitude: 42.8193
- Longitude: -83.2845
- Metro Code: 505
- Timezone: America/Detroit
- Postal: 48371
More informations about "DeNovaMed"
Developing Novel Antibiotics - About Us - DeNovaMed
DeNovaMed Inc. is at the forefront of pharmaceutical innovation, dedicated to the discovery and development of life-saving antibiotics. With a deep-seated …See details»
DeNovaMed - LinkedIn
At DeNovaMed, innovation is the heart of our operations. Our state-of-the-art computer-aided drug design capabilities have yielded multiple classes of …See details»
DeNovaMed - Crunchbase Company Profile & Funding
DeNovaMed is an early-stage pharmaceutical company specializing in new …See details»
DeNovaMed 2025 Company Profile: Valuation, Funding …
Information on valuation, funding, cap tables, investors, and executives for …See details»
DeNovaMed Company Profile - Office Locations, Competitors
DeNovaMed has 1 employees across 2 locations. See insights on DeNovaMed including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
DeNovaMed Inc Company Profile | Halifax, NS, Canada
Find company research, competitor information, contact details & financial data for DeNovaMed Inc of Halifax, NS. Get the latest business insights from Dun & Bradstreet.See details»
DeNovaMed - Overview, News & Similar companies | ZoomInfo.com
View DeNovaMed (www.denovamed.com) location in Nova Scotia, Canada , revenue, industry and description. Find related and similar companies as well as employees by title and much …See details»
DeNovaMed, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
DeNovaMed, Inc. is a company that specializes in creating antibiotics to combat infections caused by drug-resistant bacteria, also known as superbugs. Their primary focus is on treating Gram …See details»
DeNovaMed - Products, Competitors, Financials, Employees, …
About DeNovaMed DeNovaMed is a company focused on developing antibiotics to treat severe bacterial infections and diabetic foot ulcers. The company produces a variety of antibiotic …See details»
DeNovaMed Company Profile | Management and Employees List
DeNovaMed Profile and History DeNovaMed is an early-stage pharmaceutical company specializing in new therapeutic approaches to combat bacterial infections. Their team has …See details»
Media release: Dalhousie University researchers, DeNovaMed Inc.
Nov 28, 2024 For the first time in over 30 years, researchers at Dalhousie University, DeNovaMed Inc. and the University of Toronto have developed a new family of antibiotics to …See details»
DeNovaMed Inc. - LinkedIn
DeNovaMed Inc. | 30 followers on LinkedIn.Scientific Director Canadian Institutes of Health Research Institute of Genetics; Professor Dalhousie University, President and CEO …See details»
Developing Novel Antibiotics - Home - DeNovaMed
Through Novel Antibiotics, DeNovaMed Champions The Fight Against The Toughest Bacterial Infections Affecting Diabetic And Other Patients.See details»
Progressing DeNovaMed’s New CEO - Entrevestor
Jun 20, 2013 The company raised more than $35 million in equity and non-dilutive capital and took its lead product through Phase 2 trials. Sullivan said DeNovaMed’s six-member team has …See details»
DeNovaMed - VentureRadar
DeNovaMed VentureRadar profile. Find out more about DeNovaMed, Antibiotics.See details»
Developing Novel Antibiotics - Contact Us - DeNovaMed
DeNovaMed Inc. is at the forefront of pharmaceutical innovation, dedicated to the discovery and development of life-saving antibiotics. Best biotech companySee details»
Novel Antibiotics - News & Publications - DeNovaMed
Nov 28, 2024 – For the first time in over 30 years, researchers at Dalhousie University, DeNovaMed Inc. and the University of Toronto have developed a new family of antibiotics to …See details»
Technology - Developing Novel Antibiotics - DeNovaMed
Our Discovery highlights DeNovaMed’s unique approach in targeting ACP synthase to disrupt lipid metabolism in bacteria using innovative technology.See details»
Media release: Dalhousie University researchers, DeNovaMed Inc.
Nov 28, 2024 - For the first time in over 30 years, researchers at Dalhousie University, DeNovaMed Inc. and the University of Toronto have developed a new family of antibiotics to …See details»
Donald Weaver, MD, PhD - DeNovaMed - Toronto BioTech
Feb 2, 2024 Donald Weaver is the Chief Medical Officer at DeNovaMed and a Professor of Medicine, Chemistry, and Pharmacy at University of Toronto / UHN, pioneering medicinal …See details»